TB 402

Known as: TB-402, TB402 monoclonal antibody 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2010-2012
01220102012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective… (More)
Is this relevant?
2013
2013
Certain patient groups are at high risk of developing venous thromboembolism (VTE), and those undergoing major orthopaedic… (More)
Is this relevant?
2012
2012
BACKGROUND TB-402 is a partially inhibiting antibody of factor VIII that is under development as a long-acting anticoagulant… (More)
Is this relevant?
2012
2012
INTRODUCTION Partial inhibition of Factor VIII (FVIII) may provide antithrombotic efficacy whilst avoiding excessive… (More)
Is this relevant?
2011
2011
BACKGROUND TB-402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from its partial… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 3
Is this relevant?
Review
2011
Review
2011
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin… (More)
  • figure 1
  • table 2
  • table 3
Is this relevant?
2010
2010
BACKGROUND TB-402, a human monoclonal antibody that partially inhibits Factor VIII activity (FVIII:C), is being developed as a… (More)
Is this relevant?